Association between DRD2, 5-HTTLPR, and ALDH2 genes and specific personality traits in alcohol- and opiate-dependent patients

Behavioural Brain Research

Volumn 250, Issue , 2013, Pages 285-292

  Wang, Tzu Yun ^a,b,e   Lee, Sheng Yu ^a,b   Chen, Shiou Lan ^b   Huang, San Yuan ^c   Chang, Yun Hsuan ^b   Tzeng, Nian Sheng ^c   Wang, Chen Lin ^b   Hui Lee, I ^a,b   Yeh, Tzung Lieh ^a,b   Yang, Yen Kuang ^a,b   Lu, Ru Band ^a,b,d  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^e Tainan Hospital   (Taiwan)

Author keywords

5 HTTLPR; Alcohol dependence; ALDH2; DRD2; Opiate dependence; Personality traits

Indexed keywords

ALCOHOL; ALDEHYDE DEHYDROGENASE ISOENZYME 2; DOPAMINE 2 RECEPTOR; OPIATE; SEROTONIN;

5 HTTLPR GENES; ADULT; ALCOHOLISM; ALDEHYDE DEHYDROGENASE 2 GENE; ARTICLE; CHARACTER STATE; CONTROLLED STUDY; DRD2 GENE; DSM-IV-TR; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; OPIATE ADDICTION; PRIORITY JOURNAL; PROMOTER REGION; QUESTIONNAIRE;

ADULT; ALCOHOLISM; ALDEHYDE DEHYDROGENASE; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; PERSONALITY; PERSONALITY INVENTORY; POLYMORPHISM, GENETIC; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, DOPAMINE D2; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TAIWAN;

EID: 84879169133     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.05.015     Document Type: Article

References (98)

1. Compton W.M., Thomas Y.F., Stinson F.S., Grant B.F. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry 2007, 64:566-576.
2. Hasin D.S., Stinson F.S., Ogburn E., Grant B.F. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry 2007, 64:830-842.
3. Huang B., Dawson D.A., Stinson F.S., Hasin D.S., Ruan W.J., Saha T.D., et al. Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: Results of the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry 2006, 67:1062-1073.
4. Tsuang M.T., Lyons M.J., Eisen S.A., Goldberg J., True W., Lin N., et al. Genetic influences on DSM-III-R drug abuse and dependence: a study of 3,372 twin pairs. American Journal of Medical Genetics 1996, 67:473-477.
5. Kreek M.J., Nielsen D.A., Butelman E.R., LaForge K.S. Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nature Neuroscience 2005, 8:1450-1457.
6. Tsuang M.T., Lyons M.J., Meyer J.M., Doyle T., Eisen S.A., Goldberg J., et al. Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Archives of General Psychiatry 1998, 55:967-972.
7. Kendler K.S., Jacobson K.C., Prescott C.A., Neale M.C. Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. American Journal of Psychiatry 2003, 160:687-695.
8. Ersche K.D., Turton A.J., Pradhan S., Bullmore E.T., Robbins T.W. Drug addiction endophenotypes: impulsive versus sensation-seeking personality traits. Biological Psychiatry 2010, 68:770-773.
9. Bouchard T.J. Genes, environment, and personality. Science 1994, 264:1700-1701.
10. Jang K.L., Livesley W.J., Vernon P.A. Heritability of the big five personality dimensions and their facets: a twin study. Journal of Personality 1996, 64:577-591.
11. Cloninger C.R., Svrakic D.M., Przybeck T.R. A psychobiological model of temperament and character. Archives of General Psychiatry 1993, 50:975-990.
12. Yacubian J., Sommer T., Schroeder K., Glascher J., Kalisch R., Leuenberger B., et al. Gene-gene interaction associated with neural reward sensitivity. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:8125-8130.
13. Cloninger C.R. Neurogenetic adaptive mechanisms in alcoholism. Science 1987, 236:410-416.
14. Cloninger C.R. A systematic method for clinical description and classification of personality variants. A proposal. Archives of General Psychiatry 1987, 44:573-588.
15. Thompson J., Thomas N., Singleton A., Piggott M., Lloyd S., Perry E.K., et al. D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 1997, 7:479-484.
16. Pohjalainen T., Rinne J.O., Nagren K., Lehikoinen P., Anttila K., Syvalahti E.K., et al. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Molecular Psychiatry 1998, 3:256-260.
17. Noble E.P. The D2 dopamine receptor gene: a review of association studies in alcoholism and phenotypes. Alcohol 1998, 16:33-45.
18. Berman S.M., Noble E.P. Reduced visuospatial performance in children with the D2 dopamine receptor A1 allele. Behavior Genetics 1995, 25:45-58.
19. Compton P.A., Anglin M.D., Khalsa-Denison M.E., Paredes A. The D2 dopamine receptor gene, addiction, and personality: clinical correlates in cocaine abusers. Biological Psychiatry 1996, 39:302-304.
20. Noble E.P., Ozkaragoz T.Z., Ritchie T.L., Zhang X., Belin T.R. Sparkes RS. D2 and D4 dopamine receptor polymorphisms and personality. American Journal of Medical Genetics 1998, 81:257-267.
21. Blum K., Noble E.P., Sheridan P.J., Montgomery A., Ritchie T., Jagadeeswaran P., et al. Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA 1990, 263:2055-2060.
22. Noble E.P. D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2003, 116B:103-125.
23. Lawford B.R., Young R.M., Noble E.P., Sargent J., Rowell J., Shadforth S., et al. The D(2) dopamine receptor A(1) allele and opioid dependence: association with heroin use and response to methadone treatment. American Journal of Medical Genetics 2000, 96:592-598.
24. Perez de los Cobos J., Baiget M., Trujols J., Sinol N., Volpini V., Banuls E., et al. Allelic and genotypic associations of DRD2 TaqI A polymorphism with heroin dependence in Spanish subjects: a case control study. Behavioral and Brain Functions 2007, 3:25.
25. Bolos A.M., Dean M., Lucas-Derse S., Ramsburg M., Brown G.L., Goldman D. Population and pedigree studies reveal a lack of association between the dopamine D2 receptor gene and alcoholism. JAMA 1990, 264:3156-3160.
26. Gejman P.V., Ram A., Gelernter J., Friedman E., Cao Q., Pickar D., et al. No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. Analysis using denaturing gradient gel electrophoresis. JAMA 1994, 271:204-208.
27. Lu R.B., Ko H.C., Chang F.M., Castiglione C.M., Schoolfield G., Pakstis A.J., et al. No association between alcoholism and multiple polymorphisms at the dopamine D2 receptor gene (DRD2) in three distinct Taiwanese populations. Biological Psychiatry 1996, 39:419-429.
28. Li T., Liu X., Zhao J., Hu X., Ball D.M., Loh el W., et al. Allelic association analysis of the dopamine D2, D3, 5-HT2A, and GABA(A)gamma2 receptors and serotonin transporter genes with heroin abuse in Chinese subjects. American Journal of Medical Genetics 2002, 114:329-335.
29. Barratt D.T., Coller J.K., Somogyi A.A. Association between the DRD2 A1 allele and response to methadone and buprenorphine maintenance treatments. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2006, 141B:323-331.
30. Crettol S., Besson J., Croquette-Krokar M., Hammig R., Gothuey I., Monnat M., et al. Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2008, 32:1722-1727.
31. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274:1527-1531.
32. Heils A., Teufel A., Petri S., Stober G., Riederer P., Bengel D., et al. Allelic variation of human serotonin transporter gene expression. Journal of Neurochemistry 1996, 66:2621-2624.
33. Heinz A., Jones D.W., Mazzanti C., Goldman D., Ragan P., Hommer D., et al. A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biological Psychiatry 2000, 47:643-649.
34. Little K.Y., McLaughlin D.P., Zhang L., Livermore C.S., Dalack G.W., McFinton P.R., et al. Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. American Journal of Psychiatry 1998, 155:207-213.
35. Feinn R., Nellissery M., Kranzler H.R. Meta-analysis of the association of a functional serotonin transporter promoter polymorphism with alcohol dependence. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2005, 133B:79-84.
36. McHugh R.K., Hofmann S.G., Asnaani A., Sawyer A.T., Otto MW The serotonin transporter gene and risk for alcohol dependence: a meta-analytic review. Drug Alcohol Dependence 2010, 108:1-6.
37. Gerra G., Garofano L., Santoro G., Bosari S., Pellegrini C., Zaimovic A., et al. Association between low-activity serotonin transporter genotype and heroin dependence: behavioral and personality correlates. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2004, 126B:37-42.
38. Ishiguro H., Saito T., Akazawa S., Mitushio H., Tada K., Enomoto M., et al. Association between drinking-related antisocial behavior and a polymorphism in the serotonin transporter gene in a Japanese population. Alcoholism, Clinical and Experimental Research 1999, 23:1281-1284.
39. Schuckit M.A., Mazzanti C., Smith T.L., Ahmed U., Radel M., Iwata N., et al. Selective genotyping for the role of 5-HT2A, 5-HT2C, and GABA alpha 6 receptors and the serotonin transporter in the level of response to alcohol: a pilot study. Biological Psychiatry 1999, 45:647-651.
40. Saiz P.A., Garcia-Portilla M.P., Florez G., Arango C., Corcoran P., Morales B., et al. Differential role of serotonergic polymorphisms in alcohol and heroin dependence. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2009, 33:695-700.
41. Nakamura M., Ueno S., Sano A., Tanabe H. The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Molecular Psychiatry 2000, 5:32-38.
42. Hu X., Oroszi G., Chun J., Smith T.L., Goldman D., Schuckit M.A. An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. Alcoholism, Clinical and Experimental Research 2005, 29:8-16.
43. Hu X.Z., Lipsky R.H., Zhu G., Akhtar L.A., Taubman J., Greenberg B.D., et al. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. American Journal of Human Genetics 2006, 78:815-826.
44. Delbruck S.J., Wendel B., Grunewald I., Sander T., Morris-Rosendahl D., Crocq M.A., et al. A novel allelic variant of the human serotonin transporter gene regulatory polymorphism. Cytogenetics and Cell Genetics 1997, 79:214-220.
45. Gelernter J., Kranzler H., Cubells J.F. Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects. Human Genetics 1997, 101:243-246.
46. Kunugi H., Hattori M., Kato T., Tatsumi M., Sakai T., Sasaki T., et al. Serotonin transporter gene polymorphisms: ethnic difference and possible association with bipolar affective disorder. Molecular Psychiatry 1997, 2:457-462.
47. Narita N., Narita M., Takashima S., Nakayama M., Nagai T., Okado N. Serotonin transporter gene variation is a risk factor for sudden infant death syndrome in the Japanese population. Pediatrics 2001, 107:690-692.
48. Thomasson H.R., Edenberg H.J., Crabb D.W., Mai X.L., Jerome R.E., Li T.K., et al. Alcohol and aldehyde dehydrogenase genotypes and alcoholism in Chinese men. American Journal of Human Genetics 1991, 48:677-681.
49. Chen C.C., Lu R.B., Chen Y.C., Wang M.F., Chang Y.C., Li T.K., et al. Interaction between the functional polymorphisms of the alcohol-metabolism genes in protection against alcoholism. American Journal of Human Genetics 1999, 65:795-807.
50. Westerink B.H., de Vries J.B. On the origin of dopamine and its metabolite in predominantly noradrenergic innervated brain areas. Brain Research 1985, 330:164-166.
51. Cesura A.M., Pletscher A. The new generation of monoamine oxidase inhibitors. Progress in Drug Research 1992, 38:171-297.
52. Lamensdorf I., Eisenhofer G., Harvey-White J., Nechustan A., Kirk K., Kopin I.J. 3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells. Brain Research 2000, 868:191-201.
53. Keung W.M., Vallee B.L. Daidzin: a potent, selective inhibitor of human mitochondrial aldehyde dehydrogenase. Proceedings of the National Academy of Sciences of the United States of America 1993, 90:1247-1251.
54. Crabb D.W., Edenberg H.J., Bosron W.F., Li T.K. Genotypes for aldehyde dehydrogenase deficiency and alcohol sensitivity. The inactive ALDH2(2) allele is dominant. The Journal of Clinical Investigation 1989, 83:314-316.
55. Yoshida A., Hsu L.C., Yasunami M. Genetics of human alcohol-metabolizing enzymes. Progress in Nucleic Acid Research and Molecular Biology 1991, 40:255-287.
56. Wurst F.M., Tabakoff B., Alling C., Aradottir S., Wiesbeck G.A., Muller-Spahn F., et al. World Health Organization/International Society for Biomedical Research on Alcoholism study on state and trait markers of alcohol use and dependence: back to the future. Alcoholism, Clinical and Experimental Research 2005, 29:1268-1275.
57. Agarwal D.P., Goedde H.W. Pharmacogenetics of alcohol metabolism and alcoholism. Pharmacogenetics. 1992, 2:48-62.
58. Wang T.Y., Lee S.Y., Chen S.L., Chen S.H., Chu C.H., Huang S.Y., et al. The aldehyde dehydrogenase 2 gene is associated with heroin dependence. Drug and Alcohol Dependence 2012, 120:220-224.
59. Endicott J., Spitzer R.L. A diagnostic interview: the schedule for affective disorders and schizophrenia. Archives of General Psychiatry 1978, 35:837-844.
60. Huang S.Y., Lin W.W., Ko H.C., Lee J.F., Wang T.J., Chou Y.H., et al. Possible interaction of alcohol dehydrogenase and aldehyde dehydrogenase genes with the dopamine D2 receptor gene in anxiety-depressive alcohol dependence. Alcoholism, Clinical and Experimental Research 2004, 28:374-384.
61. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 1998, 59(Suppl 20):4-57. 22-33;quiz.
62. Lung F.W., Cheng C.T., Chang W.T., Shu B.C. Anxiety and mood disorder in young males with mitral valve prolapse. Journal of Multidisciplinary Healthcare 2008, 1:89-92.
63. Chen W.J., Chen H.M., Chen C.C., Yu W.Y., Cheng A.T. Cloninger's tridimensional personality questionnaire: psychometric properties and construct validity in Taiwanese adults. Comprehensive Psychiatry 2002, 43:158-166.
64. Grandy D.K., Zhang Y., Civelli O. PCR detection of the TaqA RFLP at the DRD2 locus. Human Molecular Genetics 1993, 2:2197.
65. Maron E., Tammiste A., Kallassalu K., Eller T., Vasar V., Nutt D.J., et al. Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression. European Neuropsychopharmacology 2009, 19:451-456.
66. Dandre F., Cassaigne A., Iron A. The frequency of the mitochondrial aldehyde dehydrogenase I2 (atypical) allele in Caucasian, Oriental and African black populations determined by the restriction profile of PCR-amplified DNA. Molecular and Cellular Probes 1995, 9:189-193.
67. *Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods 2007, 39:175-191.
68. *Power 3.1: tests for correlation and regression analyses. Behavior Research Methods 2009, 41:1149-1160.
69. Bowirrat A., Oscar-Berman M. Relationship between dopaminergic neurotransmission, alcoholism, and reward deficiency syndrome. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2005, 132B:29-37.
70. Kirby L.G., Zeeb F.D., Winstanley C.A. Contributions of serotonin in addiction vulnerability. Neuropharmacology 2011, 61:421-432.
71. Gingrich J.A., Hen R. Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice. Psychopharmacology (Berl) 2001, 155:1-10.
72. Volkow N.D., Wang G.J., Maynard L., Fowler J.S., Jayne B., Telang F., et al. Effects of alcohol detoxification on dopamine D2 receptors in alcoholics: a preliminary study. Psychiatry Research 2002, 116:163-172.
73. Enoch M.A., Gorodetsky E., Hodgkinson C., Roy A., Goldman D. Functional genetic variants that increase synaptic serotonin and 5-HT3 receptor sensitivity predict alcohol and drug dependence. Molecular Psychiatry 2011, 16:1139-1146.
74. Keung W.M., Klyosov A.A., Vallee B.L. Daidzin inhibits mitochondrial aldehyde dehydrogenase and suppresses ethanol intake of Syrian golden hamsters. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:1675-1679.
75. Keung W.M., Vallee B.L. Daidzin and its antidipsotropic analogs inhibit serotonin and dopamine metabolism in isolated mitochondria. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:2198-2203.
76. Keung W.M. Anti-dipsotropic isoflavones: the potential therapeutic agents for alcohol dependence. Medicinal Research Reviews 2003, 23:669-696.
77. Muramatsu T., Wang Z.C., Fang Y.R., Hu K.B., Yan H., Yamada K., et al. Alcohol and aldehyde dehydrogenase genotypes and drinking behavior of Chinese living in Shanghai. Human Genetics 1995, 96:151-154.
78. Peng G.S., Wang M.F., Chen C.Y., Luu S.U., Chou H.C., Li T.K., et al. Involvement of acetaldehyde for full protection against alcoholism by homozygosity of the variant allele of mitochondrial aldehyde dehydrogenase gene in Asians. Pharmacogenetics 1999, 9:463-476.
79. Weiner H. Relationship between 3,4-dihydroxyphenylacetaldehyde levels and tetrahydropapaveroline formation. Alcoholism, Clinical and Experimental Research 1978, 2:127-131.
80. Deitrich R., Erwin V. Biogenic amine-aldehyde condensation products: tetrahydroisoquinolines and tryptolines (beta-carbolines). Annual Review of Pharmacology and Toxicology 1980, 20:55-80.
81. Grobe N., Ren X., Kutchan T.M., Zenk M.H. An (R)-specific N-methyltransferase involved in human morphine biosynthesis. Archives of Biochemistry and Biophysics 2011, 506:42-47.
82. Fertel R.H., Greenwald J.E., Schwarz R., Wong L., Bianchine J. Opiate receptor binding and analgesic effects of the tetrahydroisoquinolines salsolinol and tetrahydropapaveroline. Research Communications in Chemical Pathology and Pharmacology 1980, 27:3-16.
83. Hamilton M.G., Hirst M., Blum K. Opiate-like activity of salsolinol on the electrically stimulated guinea pig ileum. Life Sciences 1979, 25:2205-2210.
84. Le Bon O., Basiaux P., Streel E., Tecco J., Hanak C., Hansenne M., et al. Personality profile and drug of choice; a multivariate analysis using Cloninger's TCI on heroin addicts, alcoholics, and a random population group. Drug and Alcohol Dependence 2004, 73:175-182.
85. Vukov M., Baba-Milkic N., Lecic D., Mijalkovic S., Marinkovic J. Personality dimensions of opiate addicts. Acta Psychiatrica Scandinavica 1995, 91:103-107.
86. Cohen L.J., Gertmenian-King E., Kunik L., Weaver C., London E.D., Galynker I. Personality measures in former heroin users receiving methadone or in protracted abstinence from opiates. Acta Psychiatrica Scandinavica 2005, 112:149-158.
87. Lin S.C., Wu P.L., Ko H.C., Wu J.Y., Huang S.Y., Lin W.W., et al. Specific personality traits and dopamine, serotonin genes in anxiety-depressive alcoholism among Han Chinese in Taiwan. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2007, 31:1526-1534.
88. Wu C.Y., Wu Y.S., Lee J.F., Huang S.Y., Yu L., Ko H.C., et al. The association between DRD2/ANKK1, 5-HTTLPR gene, and specific personality trait on antisocial alcoholism among Han Chinese in Taiwan. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2008, 147B:447-453.
89. Cloninger C.R., Sigvardsson S., Gilligan S.B., von Knorring A.L., Reich T., Bohman M. Genetic heterogeneity and the classification of alcoholism. Advances in Alcohol and Substance Abuse 1988, 7:3-16.
90. Galen L.W., Henderson M.J., Whitman R.D. The utility of novelty seeking, harm avoidance, and expectancy in the prediction of drinking. Addictive Behaviors 1997, 22:93-106.
91. Osher Y., Hamer D., Benjamin J. Association and linkage of anxiety-related traits with a functional polymorphism of the serotonin transporter gene regulatory region in Israeli sibling pairs. Molecular Psychiatry 2000, 5:216-219.
92. Samochowiec J., Rybakowski F., Czerski P., Zakrzewska M., Stepien G., Pelka-Wysiecka J., et al. Polymorphisms in the dopamine, serotonin, and norepinephrine transporter genes and their relationship to temperamental dimensions measured by the Temperament and Character Inventory in healthy volunteers. Neuropsychobiology 2001, 43:248-253.
93. Lu Y.A., Lee S.Y., Chen S.L., Chen S.H., Chu C.H., Tzeng N.S., et al. Gene-temperament interactions might distinguish between bipolar I and bipolar II disorders: a cross-sectional survey of Han Chinese in Taiwan. Journal of Clinical Psychiatry 2012, 73:339-345.
94. Kumakiri C., Kodama K., Shimizu E., Yamanouchi N., Okada S., Noda S., et al. Study of the association between the serotonin transporter gene regulatory region polymorphism and personality traits in a Japanese population. Neuroscience Letters 1999, 263:205-207.
95. Gawin F.H., Kleber H.D. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations. Archives of General Psychiatry 1986, 43:107-113.
96. Wise R.A., Bozarth M.A. A psychomotor stimulant theory of addiction. Psychological Review 1987, 94:469-492.
97. McGue M., Slutske W., Iacono W.G. Personality and substance use disorders: II. Alcoholism versus drug use disorders. Journal of Consulting and Clinical Psychology 1999, 67:394-404.
98. *1 and DRD2/ANKK1 TaqI A1A1 genes may be associated with antisocial personality disorder not co-morbid with alcoholism. Addiction Biology 2012, 17:865-874.